Predictive Oncology Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Predictive Oncology Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2013 to Q2 2024.
  • Predictive Oncology Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $307.000.
  • Predictive Oncology Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was -$12.1K.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.04K, a 98.1% decline from 2022.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2022 was $109K, a 26% decline from 2021.
  • Predictive Oncology Inc. annual Share-based Payment Arrangement, Expense for 2021 was $147K, a 81.2% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$12.1K $307* -$5.57K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$6.52K $734 -$8.55K -92.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $2.04K -$27.4K -$33.1K -581% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $35.2K $14.3K -$12.7K -47% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $47.9K $5.87K -$33.5K -85.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $81.4K $9.29K -$27.2K -74.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $109K $5.7K +$486K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$378K $27K -$2.01K -6.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$376K $39.4K +$6.14K +18.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$382K $36.5K -$529K -93.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $147K -$481K -$703K -316% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-21
Q3 2021 $850K $29K -$106K -78.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $956K $33.2K -$102K -75.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $1.06M $565K +$277K +96.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $780K $223K -$23.2K -9.45% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $804K $135K -$225K -62.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $1.03M $135K -$1.25M -90.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $2.27M $288K +$24.2K +9.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $2.25M $246K -$78.6K -24.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $2.33M $360K +$20.2K +5.94% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $2.31M $1.38M +$1.15M +490% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $1.16M $264K +$37.2K +16.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q4 2018 $1.12M $325K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-01
Q3 2018 $340K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-15
Q2 2018 $234K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 $226K +$127K +128% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $99.3K +$61.5K +163% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2016 $37.8K -$34.3K -47.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q1 2015 $72.1K -$187K -72.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-23
Q1 2014 $259K -$1.07M -80.5% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-18
Q1 2013 $1.33M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.